Skip to main content

Rapid Rise of Alzheimer's Disease Predicted in China and India

  • Synopsis: Published: 2013-02-21 - Emerging countries such as India and China expected to see rapid increase in Alzheimer cases during the coming years. For further information pertaining to this article contact: GlobalData.
Alzheimer's Disease
Alzheimer's Disease - Dementia is a loss of brain function that occurs with certain diseases. Alzheimer's disease (AD), is one form of dementia that gradually gets worse over time. It affects memory, thinking, and behavior. Mild cognitive impairment is the stage between normal forgetfulness due to aging, and the development of AD. People with MCI have mild problems with thinking and memory that do not interfere with everyday activities. They are often aware of the forgetfulness. Not everyone with MCI develops AD. Medicines are used to help slow down the rate at which symptoms become worse.

Main Document

Quote: "As life expectancy continues to grow, thanks to advances in medicine and medical technologies, the resulting growth in the elderly population will inevitably increase the number of people living with Alzheimer's disease"

Alzheimer's Disease to Rise Rapidly in Emerging Nations such as China and India, Says GlobalData Report.

While developed nations such as the US and Japan are already struggling with the strain of Alzheimer's disease upon society, emerging countries such as India and China are now expected to see a rapid increase in Alzheimer's cases during the coming years, due to phenomenal growth in their elderly populations, states a new report from research and consulting firm GlobalData.

GlobalData's report*, which forecasts prevalent cases of Alzheimer's disease segmented by sex and age for the population aged 60 and over in each country, states that 12.5 million people are currently living with Alzheimer's disease across the nine major markets covered; namely the US, France, Germany, Italy, Spain, the UK, Japan, China, and India.

This figure is expected to increase by 33.5% over the next decade to a total of 16.7 million prevalent cases in 2022, as rapidly aging populations in different parts of the world lead to an explosive increase in the global burden of Alzheimer's disease.

Throughout the forecast period, GlobalData believe that the US and China will have the highest number of prevalent cases of Alzheimer's disease, with higher numbers than the five EU countries combined, while India will demonstrate the fastest growth rate.

Alzheimer's disease is an irreversible, neurodegenerative brain disease associated with a progressive decline in memory, thinking, language and learning capacity.

The condition represents an escalating international health crisis, and is the most common cause of dementia and dependence among elderly individuals. Alzheimer's disease has several known risk factors, encompassing genetics, metabolic disorders, and mental health issues, but disease risk primarily increases with age, almost doubling every five years after one reaches 65.

As life expectancy continues to grow, thanks to advances in medicine and medical technologies, the resulting growth in the elderly population will inevitably increase the number of people living with Alzheimer's disease, for which there is currently no cure. Rising patient numbers means that national healthcare systems, families and caregivers are likely to feel the strain, and another upcoming report from GlobalData's PharmaPoint series will look at how important Alzheimer's disease management will be in facing critical challenges with respect to resources, funding and prioritizing by governments.

This report provides an overview of the risk factors and comorbidities associated with Alzheimer's disease, as well as global trends in prevalence in the seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging markets China and India. It also includes a 10-year epidemiological forecast of prevalent cases of Alzheimer's segmented by sex and age.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData's team of industry experts.

GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

Epicast Report: Alzheimer's Disease - Epidemiology Forecast to 2022

Related Information:

  1. Global Standardization of Biomarkers for Alzheimer's Disease - Innovative global research initiatives taking important steps to standardize Alzheimers disease biomarkers - (Published 2011-07-17).
  2. New Criteria and Guidelines for the Diagnosis of Alzheimer's Disease - Clinical diagnostic criteria for Alzheimers disease dementia and mild cognitive impairment MCI due to Alzheimers - (Published 2011-04-19).
  3. Degeneration Process Leading to Alzheimer's Cracked by McGill Researchers - A research group has uncovered a critical process in understanding the degeneration of brain cells sensitive to Alzheimers disease - (Published 2012-03-14).

Information from our Disability News: India section - (Full List).


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.

Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.

List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.

Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.

  1. Getting a Job with a Disability - Infographic with Transcript
  2. New Sports and Disciplines for Paris 2024 Paralympics
  3. Video Game Improves Balance in Youth With Autism
  4. Medicare Part B Increase Will Consume Retirees Entire COLA